EUVIMEDEUVIMED entdecken
Open Access

Psychosocial Outcomes Following Targeted Muscle Reinnervation in Patients with Neuropathic Pain

Floris V Raasveld, Tsong-Hann Yu, Jim Ho, Barbara Gomez-Eslava, Maximilian Mayrhofer-Schmid, Clifford J Woolf, William Renthal, David Hao, Ian L Valerio, Kyle R Eberlin iD

Pain Medicine · 2026

DOI: 10.1093/pm/pnag023 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pain Medicine, 2026. Verfasst von Floris V Raasveld und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Plastic and Reconstructive Surgery, Department of General Surgery, Massachusetts General Hospital, Harvard University, Boston, MA, United…. Hauptthemen laut MEDLINE: Neuralgia, Muscle, Skeletal. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, NINDS NIH HHS, Jesse B. Jupiter Research Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Neuropathic pain significantly impacts quality of life (QoL), mental health, and function. Targeted Muscle Reinnervation (TMR) is an intervention that can effectively treat and prevent neuropathic pain, but its effects on psychosocial outcomes remain underexplored. This study evaluates psychosocial outcomes following TMR surgery for neuropathic pain in both amputees (both primary pTMR and secondary sTMR) and non-amputees.

Methods

In this prospective study, 46 patients (15 sTMR, 19 pTMR, 12 non-amputees) who underwent TMR for neuropathic pain management were assessed for psychosocial outcomes. Pre- and post-operative surveys measured pain catastrophizing (PROMIS), depression (PHQ-2), anxiety (GAD-2), sleep metrics (PROMIS Sleep Disturbance, sleep duration), and QoL (WHOQOL-2). Mean follow-up was 1.5 ± 0.8 years.

Results

Pain catastrophizing significantly decreased across all groups (overall from 50.39 ± 6.24 to 42.41 ± 4.40, p < 0.001). Depression and Anxiety scores improved significantly in the non-amputee and pTMR groups, but not in sTMR patients. Sleep disturbance decreased significantly in all groups (from 59.67 ± 8.64 to 51.82 ± 8.01, p < 0.001), while sleep duration increased (from 5.32 ± 1.63 to 6.09 ± 1.29 hours, p < 0.001). QoL scores improved significantly across all groups (from 2.45 ± 0.87 to 3.43 ± 0.62, p < 0.001). Patients with psychiatric comorbidities (60.9%) showed similar improvements, despite having higher pre- and post-operative depression and anxiety scores.

Conclusions

Patients who underwent TMR for neuropathic pain management demonstrated improved psychosocial outcomes. Non-amputees and pTMR patients demonstrated greater improvements in depression and anxiety compared to sTMR patients. Sleep quality and duration improved substantially, a previously underreported benefit of TMR. Future, larger prospective studies should further validate relationship between neuropathic pain reduction through TMR and psychosocial outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeuralgiaMuscle, SkeletalHumansMaleFemaleMiddle AgedQuality of LifeProspective StudiesAdultTreatment OutcomeCatastrophizationAgedDepression

Stichwörter der Autor:innen

Targeted muscle reinnervationneuropathic painpatient-reported outcomespsychosocial outcomesquality of lifesleep disturbance

Autor:innen und Institutionen

  • Division of Plastic and Reconstructive Surgery, Department of General Surgery, Massachusetts General Hospital, Harvard University, Boston, MA, United States.
  • Hand and Arm Center, Department of Orthopaedic Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States.
  • Department of Plastic, Reconstructive and Hand Surgery, Erasmus Medical Center, Erasmus University, Rotterdam, the Netherlands.
  • Department of Orthopaedic Surgery, Tri-Service General Hospital and School of Medicine, National Defense Medical University, Taipei, Taiwan.
  • F.M. Kirby Neurobiology Center, Boston Children's Hospital and Department of Neurobiology, Harvard Medical School, Boston, MA, United States.
  • Department of Hand, Replantation and Microsurgery, Center for Musculoskeletal Surgery, Charité University Medicine, BG Unfallklinikum, Berlin, Germany.

ORCID-Profile: Kyle R Eberlin

Förderung

  • NIH HHS
  • NINDS NIH HHS
  • Jesse B. Jupiter Research Fund
  • Wyss Medical Foundation

Zitieren

APA

Raasveld, F. V., Yu, T. H., Ho, J., Gomez-Eslava, B., Mayrhofer-Schmid, M., Woolf, C. J., Renthal, W., Hao, D., Valerio, I. L., & Eberlin, K. R. (2026). Psychosocial Outcomes Following Targeted Muscle Reinnervation in Patients with Neuropathic Pain. Pain Medicine. https://doi.org/10.1093/pm/pnag023

Vancouver

Raasveld FV, Yu TH, Ho J, Gomez-Eslava B, Mayrhofer-Schmid M, Woolf CJ, et al. Psychosocial Outcomes Following Targeted Muscle Reinnervation in Patients with Neuropathic Pain. Pain Medicine. 2026. doi:10.1093/pm/pnag023

BibTeX
@article{Raasveld2026,
  author = {Raasveld, Floris V and Yu, Tsong-Hann and Ho, Jim and Gomez-Eslava, Barbara and Mayrhofer-Schmid, Maximilian and Woolf, Clifford J and Renthal, William and Hao, David and Valerio, Ian L and Eberlin, Kyle R},
  title = {Psychosocial Outcomes Following Targeted Muscle Reinnervation in Patients with Neuropathic Pain},
  journal = {Pain Medicine},
  year = {2026},
  doi = {10.1093/pm/pnag023}
}
Kostenlos starten →